Pulike Biological Engineering

Pulike Biological Engineering Current Liabilities

The Current Liabilities of Pulike Biological Engineering (603566.SS) as of Oct 18, 2026 is 136.48 M CNY. In the previous year, Current Liabilities was 493.58 M CNY — a change of -72.35% (lower).

Current Liabilities

136.48 MCNY

YoY

-72.35%

Last updated:

Current Liabilities of Pulike Biological Engineering is 2025 136.48 M CNY. Current Liabilities of Pulike Biological Engineering was 2024 493.58 M CNY. It decreases by -72.35% lower compared to the previous year.

The Pulike Biological Engineering Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
244.19 M CNY
Jan 1, 2019
232.23 M CNY
Jan 1, 2020
298.39 M CNY
Jan 1, 2021
374.92 M CNY
Jan 1, 2022
584.84 M CNY
Jan 1, 2023
203.18 M CNY
Jan 1, 2024
493.58 M CNY
Jan 1, 2025
136.48 M CNY
The Pulike Biological Engineering Current Liabilities history
YEARCurrent LiabilitiesYoY
136.48 MCNY-72.35%
493.58 MCNY+142.93%
203.18 MCNY-65.26%
584.84 MCNY+55.99%
374.92 MCNY+25.65%
298.39 MCNY+28.49%
232.23 MCNY-4.90%
244.19 MCNY+8.17%
225.75 MCNY+10.58%
204.16 MCNY+35.58%
150.59 MCNY+14.82%
131.15 MCNY+8.14%
121.29 MCNY-9.48%
133.98 MCNY-21.26%
170.16 MCNY-14.55%
199.13 MCNY+219.28%
62.37 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc, listed on the Shanghai Stock Exchange with ticker 603566.SS and ISIN CNE1000025N0, is a pharmaceutical company based in Luoyang, China. The company went public on May 18, 2015. It employs 1,718 people and operates within the healthcare sector, specifically in the pharmaceuticals industry. Pulike Biological Engineering focuses on the research, development, manufacturing, and sale of biological products for animals, chemical drugs, and Chinese veterinary drugs. The company's veterinary biological products include vaccines and antibodies, which are used for the prevention and control of infectious diseases in poultry and livestock. Its veterinary chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. The company is headquartered in Luoyang, Henan, and its website is http://www.pulike.com.cn/. Pulike Biological Engineering Inc is engaged in the research, development, production, and distribution of veterinary biological products and chemical medicines. The firm's product portfolio targets the prevention and treatment of diseases in animals, with a focus on poultry and livestock health management. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

Current Liabilities of Pulike Biological Engineering is 136.48 M CNY in 2025.

Current Liabilities of Pulike Biological Engineering changed from 493.58 M CNY to 136.48 M CNY, representing a -72.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Pulike Biological Engineering historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Pulike Biological Engineering

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Pulike Biological Engineering